A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 186 200 KRW -0.32% Market Closed
Market Cap: 10.3T KRW

ABL Bio Inc
Tax Provision

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

ABL Bio Inc
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Tax Provision
â‚©0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Tax Provision
-â‚©160.7B
CAGR 3-Years
-6%
CAGR 5-Years
-3%
CAGR 10-Years
-35%
SK Bioscience Co Ltd
KRX:302440
Tax Provision
â‚©39B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Voronoi Inc
KOSDAQ:310210
Tax Provision
â‚©32.2m
CAGR 3-Years
-49%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Tax Provision
-â‚©36.4B
CAGR 3-Years
-39%
CAGR 5-Years
-44%
CAGR 10-Years
-29%
Alteogen Inc
KOSDAQ:196170
Tax Provision
â‚©9.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
58%
No Stocks Found

ABL Bio Inc
Glance View

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
15 855.97 KRW
Overvaluation 91%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Tax Provision?
Tax Provision
0 KRW

Based on the financial report for Jun 30, 2025, ABL Bio Inc's Tax Provision amounts to 0 KRW.

Back to Top